Navigation Links
NASDAQ Gives Dynatronics a Second Six-Month Extension for Minimum Bid Price Compliance
Date:12/15/2010

SALT LAKE CITY, Dec. 15, 2010 /PRNewswire/ -- Dynatronics Corporation (Nasdaq: DYNT) today announced that NASDAQ has given the company until June 13, 2011, to comply with its $1 per share minimum bid rule.

"Given the challenges of the general economy, we welcome the grant by NASDAQ of an additional six months to cure the $1 minimum bid deficiency," stated Kelvyn H. Cullimore Jr., chairman and president of Dynatronics. "These difficult economic times have made it challenging for small public companies to maintain strength in their stock prices.  This extra time will provide an opportunity for the market to better understand the potential of some important new developments that we expect to announce over the coming weeks and months."

"Dynatronics' newly introduced e-commerce website is positively impacting sales and helping the company operate more efficiently.  In addition, we are working to capitalize on preferred vendor contracts signed over the past year as well as identify and introduce new products to the market," Cullimore added.

"Our preferred vendor contracts give us access to over 2,500 clinics that we are working to convert to our brand of products. This promises to be a source of increased revenue over the coming year as more clinics choose to purchase our devices and supplies," Cullimore continued. "We believe all of these improvements, together with the new initiatives being undertaken that we expect to disclose in the coming weeks and months, should continue to strengthen our business and build investor confidence in owning our stock."

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at www.dynatronics.com.

This press release contains forward-looking statements. Those statements include references to the company's expectations and similar statements such as the statement regarding expectations for future announcements, increased revenue from preferred vendor contracts and continued strengthening in our business. Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, availability of financing at cost effective rates, and the risk factors listed from time to time in the company's SEC reports including, but not limited to, the report on Form 10-K for the year ended June 30, 2010.


'/>"/>
SOURCE Dynatronics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Nile Therapeutics Receives NASDAQ Notice; Will Request Hearing
2. Marshall Edwards Receives NASDAQ Notice Of Non-Compliance; Intends To Request Hearing
3. Penwest Pharmaceuticals Announces Intention to Terminate NASDAQ Listing and Registration
4. EntreMed Receives Notice of NASDAQ Compliance
5. Cyberonics Reports Inducement Equity Awards Under NASDAQ Listing Rule 5635(c)(4)
6. ThermoGenesis Regains Compliance With NASDAQ Listing Rules
7. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
8. ThermoGenesis Announces Reverse Stock Split Effective on NASDAQ Capital Market August 27, 2010
9. Jiangbo Pharmaceuticals Chairman to Ring NASDAQ Opening Bell on August 27, 2010
10. EntreMed Receives NASDAQ Listing Rule 5550(b)(2) Determination Letter
11. Poniard Pharmaceuticals Receives NASDAQ Deficiency Notice Related to Minimum Bid Price
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star ... , Millions of individuals in the United States and Canada wear eyeglasses. Once considered ... both correct vision and make a fashion statement. Even celebrities use glasses as a ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a ... and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is ... to some of the world’s leading providers of cereal and other breakfast foods. Its ...
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
Breaking Medicine News(10 mins):